Literature DB >> 16333648

[Botulinum toxin therapy in orthopaedics].

L Döderlein1.   

Abstract

Botulinum toxin A plays an important role in the conservative management of problems of the musculoskeletal system. The main indications for its use are disorders of muscle tone and spasticity of various origins, which makes botulinum toxin an important focal treatment in many neurological conditions. Nevertheless, every orthopaedic surgeon who is involved in the conservative management of muscular problems should be familiar with the indications as well as the pharmacology of the substance and its proper injection techniques. By a combination of botulinum toxin injections with a variety of other conservative measures, such as orthotics and plaster cast treatment, its effect can be enhanced and prolonged. Due to the reversibility of its action, exact dose adjustment to the individual is possible.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16333648     DOI: 10.1007/s00132-005-0902-x

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  23 in total

Review 1.  Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions.

Authors:  K R Aoki; B Guyer
Journal:  Eur J Neurol       Date:  2001-11       Impact factor: 6.089

2.  Treatment of idiopathic clubfoot utilizing botulinum A toxin: a new method and its short-term outcomes.

Authors:  Christine M Alvarez; Stephen J Tredwell; Sean P Keenan; Richard D Beauchamp; Rachel L Choit; Bonita J Sawatzky; Mary A De Vera
Journal:  J Pediatr Orthop       Date:  2005 Mar-Apr       Impact factor: 2.324

3.  Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection.

Authors:  R L Rosales; K Arimura; S Takenaga; M Osame
Journal:  Muscle Nerve       Date:  1996-04       Impact factor: 3.217

4.  Development of resistance to botulinum toxin type A in patients with torticollis.

Authors:  P Greene; S Fahn; B Diamond
Journal:  Mov Disord       Date:  1994-03       Impact factor: 10.338

5.  Repeated botulinum toxin A injections in the treatment of spastic equinus foot.

Authors:  Dimitrios Metaxiotis; Andrea Siebel; Leonhard Doederlein
Journal:  Clin Orthop Relat Res       Date:  2002-01       Impact factor: 4.176

Review 6.  Recommendations for the use of botulinum toxin type A in the management of cerebral palsy.

Authors:  H K Graham; K R Aoki; I Autti-Rämö; R N Boyd; M R Delgado; D J Gaebler-Spira; M E Gormley; B M Guyer; F Heinen; A F Holton; D Matthews; G Molenaers; F Motta; P J García Ruiz; J Wissel
Journal:  Gait Posture       Date:  2000-02       Impact factor: 2.840

7.  Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences.

Authors:  G Molenaers; K Desloovere; J De Cat; I Jonkers; L De Borre; P Pauwels; J Nijs; G Fabry; P De Cock
Journal:  Eur J Neurol       Date:  2001-11       Impact factor: 6.089

8.  Botulinum toxin in the management of the lower limb in cerebral palsy.

Authors:  A P Cosgrove; I S Corry; H K Graham
Journal:  Dev Med Child Neurol       Date:  1994-05       Impact factor: 5.449

9.  [Botulinum toxin A in the treatment of infantile cerebral palsy. Taking into account multilevel, integrated treatment].

Authors:  G Molenaers; K Desloovere; J De Cat
Journal:  Orthopade       Date:  2004-10       Impact factor: 1.087

10.  Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.

Authors:  C M Shaari; I Sanders
Journal:  Muscle Nerve       Date:  1993-09       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.